Skip to main content

Table 4 Contribution of the seven areas to the estimates of net monetary benefit by year: 1991 to 2010 (QALY value of £25,000)

From: Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes

  Net monetary benefit (£ million)
Year Treatment Screening Smoking reduction Total
Prostate cancer Breast cancer Colorectal cancer Cervical cancer Bowel cancer Breast cancer
1991 8 490 -33 1729 7 3885 6085
1992 8 506 -35 1699 7 3889 6075
1993 9 485 -33 1659 8 3890 6018
1994 10 504 -32 1646 8 3894 6030
1995 9 475 -28 1592 8 3906 5963
1996 -3 483 -28 1609 9 3920 5989
1997 -3 458 -28 1546 11 3933 5916
1998 -3 531 -29 1447 10 3947 5902
1999 -10 566 -40 1374 9 3966 5866
2000 -15 579 -36 1350 9 3989 5876
2001 -25 630 -30 1310 9 4018 5910
2002 -8 647 -5 1283 9 4037 5963
2003 -14 677 24 1294 9 4035 6025
2004 -7 705 49 1376 9 4064 6195
2005 -15 694 67 1460 9 4099 6314
2006 -16 697 106 1484 64 9 4138 6481
2007 -23 736 149 1469 128 9 4167 6635
2008 51 786 171 1474 192 10 4192 6876
2009 46 816 178 1528 256 10 4216 7050
2010 66 854 183 1596 320 11 4253 7282
Total 65 12318 566 29927 960 179 80437 124452
  1. Abbreviation: QALY quality adjusted life year.